MCM
TAK icon

MAI Capital Management’s Takeda Pharmaceutical TAK Stock Holding History

MAI Capital Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$166K Buy
10,292
+7,397
+256% +$122K ﹤0.01% 1842
2026
Q1 		$53.6K Buy
2,895
+815
+39% +$14.3K ﹤0.01% 2184
2025
Q4 		$32.4K Sell
2,080
-456
-18% -$6.52K ﹤0.01% 2257
2025
Q3 		$37.1K Sell
2,536
-2,641
-51% -$39.2K ﹤0.01% 2097
2025
Q2 		$80K Buy
5,177
+3,520
+212% +$52K ﹤0.01% 1598
2025
Q1 		$24.6K Buy
1,657
+60
+4% +$841 ﹤0.01% 2093
2024
Q4 		$21.1K Buy
+1,597
New +$21.9K ﹤0.01% 2194
2021
Q3 		– Sell
-19,135
Closed -$322K – 854
2021
Q2 		$322K Sell
19,135
-1,767
-8% -$30.1K 0.01% 580
2021
Q1 		$382K Buy
20,902
+591
+3% +$10.6K 0.01% 530
2020
Q4 		$370K Sell
20,311
-917
-4% -$16.1K 0.01% 504
2020
Q3 		$379K Sell
21,228
-371
-2% -$6.75K 0.01% 441
2020
Q2 		$387K Sell
21,599
-2,608
-11% -$46.8K 0.01% 428
2020
Q1 		$367K Buy
24,207
+688
+3% +$12.5K 0.02% 413
2019
Q4 		$464K Buy
+23,519
New +$450K 0.02% 401
2019
Q3 		– Sell
-11,974
Closed -$212K – 559
2019
Q2 		$212K Sell
11,974
-1,789
-13% -$32.6K 0.01% 487
2019
Q1 		$280K Buy
+13,763
New +$277K 0.01% 358

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

MAI Capital Management's TAK Position: Q2 2026 in Review

MAI Capital Management increased its Takeda Pharmaceutical (TAK) stake by 256% in Q2 2026, buying an estimated $122K and bringing the position to 10,292 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #1842.

MAI Capital Management first reported a position in TAK in Q1 2019 and has held it in 16 quarters since. The position peaked at $464K in Q4 2019. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • MAI Capital Management held 10,292 shares of Takeda Pharmaceutical worth $166K as of Q2 2026.
  • MAI Capital Management bought 7,397 Takeda Pharmaceutical shares in Q2 2026, an estimated $122K.
  • Takeda Pharmaceutical made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #1842 holding.
  • MAI Capital Management first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 16 quarters since.
  • MAI Capital Management's Takeda Pharmaceutical position peaked at $464K in Q4 2019.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.